Asia Pacific Carbapenem-Based Antibiotics Market to Grow at a CAGR of 5.0% to reach US$ 1,506.07 Million from 2021 to 2028

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Asia Pacific Carbapenem-based Antibiotics Market – By Type

1.3.2 Asia Pacific Carbapenem-based Antibiotics Market – By Indication

1.3.3 Asia Pacific Carbapenem-based Antibiotics Market – By Distribution Channel

1.3.4 Asia Pacific Carbapenem-based Antibiotics Market – By Country

2. Carbapenem-based Antibiotics Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Asia Pacific Carbapenem-based Antibiotics Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Asia Pacific– PEST Analysis

4.3 Expert Opinions

5. Carbapenem-based Antibiotics Market – Key Market Dynamics

5.1 Drivers

5.1.1 Rising Prevalence of Gram-Negative Bacterial Infections

5.1.2 Increasing Production of Generic Drugs

5.2 Market Restraints

5.2.1 Tedious and Expensive Process of Antibiotic Development

5.3 Market Opportunities

5.3.1 Private and Public Partnerships

5.4 Future Trends

5.4.1 Strategic Advancement for New Antibiotic Identification

5.5 Impact Analysis

6. Carbapenem-based Antibiotics Market –Asia Pacific Analysis

6.1 Asia Pacific Carbapenem-based Antibiotics Market Revenue Forecast and Analysis

7. Carbapenem-based Antibiotics Market Analysis – By Type

7.1 Overview

7.2 Carbapenem-based Antibiotics Market Revenue Share, by Type (2021 and 2028)

7.3 Meropenem

7.3.1 Overview

7.3.2 Meropenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Doripenem

7.4.1 Overview

7.4.2 Doripenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Imipenem

7.5.1 Overview

7.5.2 Imipenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

7.6 Tebipenem

7.6.1 Overview

7.6.2 Tebipenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

7.7 Others

7.7.1 Overview

7.7.2 Others: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

8. Carbapenem-based Antibiotics Market – By Indication

8.1 Overview

8.2 Carbapenem-based Antibiotics Market, by Indication, 2021 and 2028 (%)

8.3 Bacterial Meningitis

8.3.1 Overview

8.3.2 Bacterial Meningitis: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Acute Pelvic Infections

8.4.1 Overview

8.4.2 Acute Pelvic Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Respiratory Tract Infections

8.5.1 Overview

8.5.2 Respiratory Tract Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Intra-abdominal Infections

8.6.1 Overview

8.6.2 Intra-abdominal Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Urinary Tract Infections

8.7.1 Overview

8.7.2 Urinary Tract Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

8.8 Others

8.8.1 Overview

8.8.2 Others: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

9. Carbapenem-based Antibiotics Market – By Distribution Channel

9.1 Overview

9.2 Carbapenem-based Antibiotics Market, by Distribution Channel, 2021 and 2028 (%)

9.3 Retail Pharmacies

9.3.1 Overview

9.3.2 Retail Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Online Pharmacies

9.4.1 Overview

9.4.2 Online Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Hospital Pharmacies

9.5.1 Overview

9.5.2 Hospital Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

10. Asia Pacific Carbapenem-based Antibiotics Market –Country Analysis

10.1 Asia Pacific: Carbapenem-based Antibiotics Market

10.1.1 Overview

10.1.2 Asia Pacific: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.3 Asia Pacific: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.1.4 Asia Pacific: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ Million)

10.1.5 Asia Pacific: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ Million)

10.1.6 Asia Pacific: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)

10.1.6.1 China: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.1.1 China: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.1.2 China: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.1.6.1.3 China: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.1.6.1.4 China: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

10.1.6.2 Japan: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.2.1 Japan: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.2.2 Japan: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.1.6.2.3 Japan: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.1.6.2.4 Japan: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

10.1.6.3 India: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.3.1 India: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.3.2 India: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.1.6.3.3 India: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.1.6.3.4 India: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

10.1.6.4 Australia: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.4.1 Australia: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.4.2 Australia: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.1.6.4.3 Australia: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.1.6.4.4 Australia: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

10.1.6.5 South Korea: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.5.1 South Korea: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.5.2 South Korea: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.1.6.5.3 South Korea: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.1.6.5.4 South Korea: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

10.1.6.6 Rest of Asia Pacific: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.6.1 Rest of Asia Pacific: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.6.2 Rest of Asia Pacific: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.1.6.6.3 Rest of Asia Pacific: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.1.6.6.4 Rest of Asia Pacific: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

11. Impact of COVID-19 Pandemic on Asia Pacific Carbapenem-based Antibiotics Market

11.1 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

12. Carbapenem-based Antibiotics Market–Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic Developments

12.3.1 Overview

13. COMPANY PROFILES

13.1 ACS Dobfar S.p.A

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 DAEWOONG PHARMACEUTICAL CO.,LTD

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Aurobindo Pharma Ltd

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Gland Pharma Limited

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Merck & Co., Inc.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Sumitomo Dainippon Pharma Co., Ltd.

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Savior Lifetec

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Pfizer Inc.

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Spero Therapeutics

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. Asia Pacific: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 2. Asia Pacific: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 3. Asia Pacific: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 4. China: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 5. China: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 6. China: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 7. Japan: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 8. Japan: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 9. Japan: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 10. India: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 11. India: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 12. India: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 13. Australia: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 14. Australia: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 15. Australia: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 16. South Korea: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 17. South Korea: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 18. South Korea: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 19. Rest of Asia Pacific: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 20. Rest of Asia Pacific: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 21. Rest of Asia Pacific: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 22. Organic Developments in the Carbapenem-based Antibiotics Market

Table 23. Inorganic Developments in the Carbapenem-based Antibiotics Market

Table 24. Glossary of Terms, Carbapenem-based Antibiotics Market

LIST OF FIGURES

Figure 1. Carbapenem-based Antibiotics Market Segmentation

Figure 2. Carbapenem-based Antibiotics Segmentation, By Country

Figure 3. Asia Pacific Carbapenem-based Antibiotics Market Overview

Figure 4. The Others Segment Held Largest Share of Type Segment in Carbapenem-based Antibiotics Market

Figure 5. Asia Pacific Carbapenem-based Antibiotics Market- Leading Country Markets (US$ Million)

Figure 6. Asia Pacific PEST Analysis

Figure 7. Carbapenem-based Antibiotics Market Impact Analysis of Driver and Restraints

Figure 8. Asia Pacific Carbapenem-based Antibiotics Market – Revenue Forecast and Analysis – 2021- 2028

Figure 9. Carbapenem-based Antibiotics Market Revenue Share, by Type (2021 and 2028)

Figure 10. Meropenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11. Doripenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. Imipenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. Tebipenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. Others: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. Carbapenem-based Antibiotics Market, by Indication, 2021 and 2028 (%)

Figure 16. Bacterial Meningitis: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. Acute Pelvic Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18. Respiratory Tract Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. Intra-abdominal Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. Urinary Tract Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. Others: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. Carbapenem-based Antibiotics Market, by Distribution Channel, 2021 and 2028 (%)

Figure 23. Retail Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. Online Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. Hospital Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. Asia Pacific: Carbapenem-based Antibiotics Market, by Key Country – Revenue (2021) (US$ ‘Million)

Figure 27. Asia Pacific: Carbapenem-based Antibiotics Market Revenue and Forecast to 2028 (US$ ‘Million)

Figure 28. Asia Pacific: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)

Figure 29. China: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 30. Japan: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 31. India: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 32. Australia: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 33. South Korea: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 34. Rest of Asia Pacific: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 35. Impact Of COVID-19 Pandemic in Asia-Pacific Country Markets